Predictors of Spontaneous and Systematically Assessed Suicidal Adverse Events in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) Study
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The authors sought to identify predictors of self-harm adverse events in treatment-resistant, depressed adolescents during the first 12 weeks of treatment. METHOD: Depressed adolescents (N=334) who had not responded to a previous trial with an SSRI antidepressant were randomized to a switch to either another SSRI or venlafaxine, with or without cognitive behavior therapy. Self-harm events, i.e., suicidal and non-suicidal self-injury adverse events were assessed by spontaneous report for the first 181 participants, and by systematic weekly assessment for the last 153 participants. RESULTS: Higher rates of suicidal (20.8% vs. 8.8%) and nonsuicidal self-injury (17.6% vs. 2.2%), but not serious adverse events (8.4% vs. 7.3%) were detected with systematic monitoring. Median time to a suicidal event was 3 weeks, predicted by high baseline suicidal ideation, family conflict, and drug and alcohol use. Median time to nonsuicidal self-injury was 2 weeks, predicted by previous history of nonsuicidal self-injury. While there were no main effects of treatment, venlafaxine treatment was associated with a higher rate of self-harm adverse events in those with higher suicidal ideation. Adjunctive use of benzodiazepines, while in a small number of participants (N=10) was associated with higher rate of both suicidal and nonsuicidal self-injury adverse events. CONCLUSIONS: Since predictors of suicidal adverse events also predict poor response to treatment, and many of these events occurred early in treatment, improving the speed of response to depression, by targeting of family conflict, suicidal ideation, and drug use may help to reduce their incidence. The relationship of venlafaxine and of benzodiazepines to self-harm events requires further study and clinical caution.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“More promisingly, antidepressants reduced suicidal ideation in 9/12 studies that reported effects on suicidal ideation.(55, 57, 59–65)”
From Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review (2021) · cites this paper as [65]
In the citing paper
“Three adolescent and young adult RCT studies found antidepressants reduced suicidal ideation,(62, 64, 65) one did not,(85) and none found a reduction in suicide behavior.”
From Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review (2021) · cites this paper as [65]
Citations
Cites
Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation
Beck, A. T., Steer, R. A., & Carbin, M. G. (1988) · Clinical Psychology Review · doi:10.1016/0272-7358(88)90050-5 · Cited by 11,696 · cited 2×
“Subjects were assigned to treatment using a variation of Efron’s biased coin toss (15), balancing both across and within sites with respect to incoming treatment medication, comorbid anxiety, chronic depression (duration ≥24 months), and BDI item 9 (suicidal ideation) ≥2.”
MethodKAUFMAN, J., BIRMAHER, B., BRENT, D., RAO, U., FLYNN, C., MORECI, P., WILLIAMSON, D., & RYAN, N. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199707000-00021 · Cited by 10,148 · cited 1×
“Diagnostic information was obtained by the School Age Schedule for Affective Disorders and Schizophrenia for School-Aged Children-Present and Lifetime Version (K-SADS-PL) ( 16 ) at baseline.”
MethodSelf-citationThe measurement of pessimism: the hopelessness scale
Beck, A. T., Weissman, A., Lester, D., & Trexler, L. (1974) · Journal of Consulting and Clinical Psychology · doi:10.1037/h0037562 · Cited by 5,494 · cited 1×
“Self-rated depression, hopelessness, and suicidal ideation were assessed using the Beck Depression Inventory (BDI) (18), Beck Hopelessness Scale (19), and Suicide Ideation Questionnaire—JR (20), respectively.”
MethodA Children's Global Assessment Scale (CGAS)
Shaffer, D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790100074010 · Cited by 3,716
Non-suicidal self-injury among adolescents: Diagnostic correlates and relation to suicide attempts
NOCK, M., JOINERJR, T., GORDON, K., LLOYDRICHARDSON, E., & PRINSTEIN, M. (2006) · Psychiatry Research · doi:10.1016/j.psychres.2006.05.010 · Cited by 1,617 · cited 1×
“Although the clinical characteristics of those with suicidal and nonsuicidal adverse events overlap ( 27 ), the clinical implications of suicidal adverse events were more serious, insofar as the occurrence of suicidal, but not nonsuicidal self-injury, adverse events was associated with a poorer response to treatment.”
BackgroundA Functional Approach to the Assessment of Self-Mutilative Behavior.
Nock, M. K., & Prinstein, M. J. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.5.885 · Cited by 1,536 · cited 1×
“A “serious suicidal or nonsuicidal self-injury adverse event” was an event that led to hospitalization, was life-threatening, disabling, or resulted in death ( 25 ).”
BackgroundBridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., Ren, L., & Brent, D. A. (2007) · JAMA · doi:10.1001/jama.297.15.1683 · Cited by 1,086 · cited 3×
“During the first half of the study, participants were monitored for self-harm adverse events by spontaneous report, similar to previous studies (1, 10).”
BackgroundResultSelf-citationSuicidality in Pediatric Patients Treated With Antidepressant Drugs
Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054 · cited 3×
“During the first half of the study, participants were monitored for self-harm adverse events by spontaneous report, similar to previous studies (1, 10).”
ResultPosner, K., Oquendo, M. A., Gould, M., Stanley, B., & Davies, M. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.7.1035 · Cited by 1,025 · cited 4×
“This scale consists of two items: 1) a rating of suicidal ideation ranging from 0 to 5 (no ideation to suicidal ideation with intent and a clear plan) and 2) a rating of suicidal behavior, ranging from 0 to 5 (no behavior to multiple attempts during the assessment period) using the Columbia Classification Algorithm of…”
BackgroundMethodInfluential(2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1132 · Cited by 752
Self-citation
Research works printed but not linked: 9
- Apter A, 2006, J Child Adolesc Psychopharmacology, 16
- Hammad T, 2004, US Food and Drug Administration., 19
- Brent DA, JAMA 2008: 901-913
- US Food and Drug Administration, 2003, FDA Talk Paper.
- American Psychiatric Association, 1994, Diagnostic and Statistical Manual of Mental Health-IV
- Poznanski EO, 1984, Depression Rating Scale-Revised. Psychopharmacol Bull, 21, 979
- Guy W, 1976, Clinical Global Improvement Scale: Assessment Manual of Psychopharmacology 76
- Robin AL, 1995, Dictionary of Behavorial Techniques, 148
- Asarnow J, Keller MB
Cited by
Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial
Rossouw, T. I., & Fonagy, P. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.09.018 · Cited by 746
Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review
Mann, J. J., Michel, C. A., & Auerbach, R. P. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20060864 · Cited by 655
Wilkinson, P., Kelvin, R., Roberts, C., Dubicka, B., & Goodyer, I. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10050718 · Cited by 645
Asarnow, J. R., Porta, G., Spirito, A., Emslie, G., Clarke, G., Wagner, K. D., Vitiello, B., Keller, M., Birmaher, B., McCracken, J., et al. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2011.04.003 · Cited by 632
Self-citationA Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013
Mrazek, D. A., Hornberger, J. C., Altar, C. A., & Degtiar, I. (2014) · Psychiatric Services · doi:10.1176/appi.ps.201300059 · Cited by 580
Psychosocial risk factors for suicidality in children and adolescents
Carballo, J. J., Llorente, C., Kehrmann, L., Flamarique, I., Zuddas, A., Purper-Ouakil, D., Hoekstra, P. J., Coghill, D., Schulze, U. M. E., Dittmann, R. W., et al. (2020) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-018-01270-9 · Cited by 378
Connecting inflammation with glutamate agonism in suicidality
Erhardt, S., Lim, C. K., Linderholm, K. R., Janelidze, S., Lindqvist, D., Samuelsson, M., Lundberg, K., Postolache, T. T., Träskman-Bendz, L., Guillemin, G. J., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.248 · Cited by 345
“…inflammation and subsequent stimulation of glutamate neurotransmission could potentially be prevalent in so-called treatment-resistant or severe depression; diagnostic groups where suicides, attempts and suicidal ideation all are common (Brent et al, 2009; Price et al, 2009; Steiner et al, 2011).”
BackgroundWalter, H. J., Bukstein, O. G., Abright, A. R., Keable, H., Ramtekkar, U., Ripperger-Suhler, J., & Rockhill, C. (2020) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2020.05.005 · Cited by 335
“Moreover, caution should be exercised when combining two or more non-MAOI serotonergic drugs, including antidepressants (eg, SSRIs, SNRIs, TCAs, atypical antidepressants); opioids and other pain medications (eg, tramadol, meperidine, methadone, fentanyl); stimulants (eg, amphetamine and possibly methylphenidate classe…”
BackgroundInfluentialWilkinson, P., & Goodyer, I. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-010-0156-y · Cited by 268
“SSRI led to a significant additional reduction in self-injury, whether suicidal and NSSI were classified together [15] or separately [16].”
Cheung, A. H., Zuckerbrot, R. A., Jensen, P. S., Laraque, D., Stein, R. E. K., GLAD-PC STEERING GROUP, Levitt, A., Birmaher, B., Campo, J., Clarke, G., et al. (2018) · Pediatrics · doi:10.1542/peds.2017-4082 · Cited by 299
“40 TCPS was subsequently expanded statewide and became known as the Massachusetts Child Psychiatry Access Project.”
Self-citationGeller, B. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1508 · Cited by 281
“Differences in prevalence of adverse events between openended questions and interviews that inquire about specific adverse occurrences have been shown.(36) The limitations of the TEAM study include that, at this point in time, there is no valid diagnostic biological measure for childhood bipolar disorders, and thus no…”
Smith, S. M., Dart, R. C., Katz, N. P., Paillard, F., Adams, E. H., Comer, S. D., Degroot, A., Edwards, R. R., Haddox, D. J., Jaffe, J. H., et al. (2013) · Pain · doi:10.1016/j.pain.2013.05.053 · Cited by 265
“Initial testing has shown this tool to be reliable, sensitive, and specific [7,27].”
MethodMacQueen, G. M., Frey, B. N., Ismail, Z., Jaworska, N., Steiner, M., Lieshout, R. J. V., Kennedy, S. H., Lam, R. W., Milev, R. V., Parikh, S. V., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659276 · Cited by 248
“This is especially true in more severely depressed patients, those with high suicidal ideation, and those experiencing family conflict.(30) The Canadian Psychiatric Association also recommends that appointments or telephone contacts should be scheduled at least weekly within the first month of treatment for children a…”
BackgroundInfluentialSeverity and Variability of Depression Symptoms Predicting Suicide Attempt in High-Risk Individuals
Melhem, N. M., Porta, G., Oquendo, M. A., Zelazny, J., Keilp, J. G., Iyengar, S., Burke, A., Birmaher, B., Stanley, B., Mann, J. J., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.4513 · Cited by 246
“The median (range) time from the last assessment point to suicide attempt was 45 (1-126) weeks (30 [4-126] weeks for actual attempt).”
BackgroundSelf-citationBrent, D. A., Greenhill, L. L., Compton, S., Emslie, G., Wells, K., Walkup, J. T., Vitiello, B., Bukstein, O., Stanley, B., Posner, K., et al. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181b5dbe4 · Cited by 262
“Our findings that high self-reported depression, high ideation at the beginning of treatment, high hopelessness, and a history of multiple attempts predicted a suicidal event are consistent with other reports.(1,6,7,34,35) Unlike other studies, we did not find that comorbid disruptive disorders were related to increas…”
Self-citationTurner, B. J., Austin, S. B., & Chapman, A. L. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405901103 · Cited by 259
Protecting Adolescents From Self-Harm: A Critical Review of Intervention Studies
Brent, D. A., McMakin, D. L., Kennard, B. D., Goldstein, T. R., Mayes, T. L., & Douaihy, A. B. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.09.009 · Cited by 223
“In addition, MI is particularly salient for decreasing substance use, an important treatment objective, given the critical role of drug and alcohol use in suicidal events and treatment nonresponse.(12,34,35) The augmentation of parent–child support and effective parental monitoring has been shown to protect against re…”
BackgroundSelf-citationWang, Z., Whiteside, S. P. H., Sim, L., Farah, W., Morrow, A. S., Alsawas, M., Barrionuevo, P., Tello, M., Asi, N., Beuschel, B., et al. (2017) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2017.3036 · Cited by 234
Cox, G. R., Callahan, P., Churchill, R., Hunot, V., Merry, S. N., Parker, A. G., & Hetrick, S. E. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008324.pub3 · Cited by 194
Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents
Strawn, J. R., Mills, J. A., Poweleit, E. A., Ramsey, L. B., & Croarkin, P. E. (2023) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2767 · Cited by 185
Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes
Emslie, G. J., Mayes, T., Porta, G., Vitiello, B., Clarke, G., Wagner, K. D., Asarnow, J. R., Spirito, A., Birmaher, B., Ryan, N., et al. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09040552 · Cited by 217
Self-citationStrawn, J. R., Geracioti, L., Rajdev, N., Clemenza, K., & Levine, A. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1491966 · Cited by 214
“In youth, SNRIs may be associated with class-specific tolerability concerns and, in fact, venlafaxine was associated with increased treatment-emergent suicidality in the Treatment of SSRIResistant Depression in Adolescents (TORDIA) study [130] and in a recent meta-analysis of antidepressants in pediatric patients with…”
ResultTuisku, V., Kiviruusu, O., Pelkonen, M., Karlsson, L., Strandholm, T., & Marttunen, M. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.09.031 · Cited by 160
Concise Health Risk Tracking Scale: A Brief Self-Report and Clinician Rating of Suicidal Risk
Trivedi, M. H., Wisniewski, S. R., Morris, D. W., Fava, M., Gollan, J. K., Warden, D., Nierenberg, A. A., Gaynes, B. N., Husain, M. M., Luther, J. F., et al. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m06837 · Cited by 164
Research Review: Pediatric Anxiety Disorders—What Have We Learnt in the Last 10 Years?
Strawn, J. R., Lu, L., Peris, T. S., Levine, A., & Walkup, J. T. (2021) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13262 · Cited by 168
Calati, R., & Courtet, P. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.04.003 · Cited by 165
“(trials on short-term psychotherapies: (Asarnow et al., 2011, Brent et al., 2009, Brown et al., 2005, Comtois et al., 2011, Diamond et al., 2010, Donaldson et al., 2005, Guthrie et al., 2001, Hawton et al., 1987, Hollon et al., 1992, McLeavey et al., 1994, Mufson et al., 2004, Rudd et al., 2015,…”
BackgroundInfluentialSuicidal behaviors in depressed adolescents: role of perceived relationships in the family
Consoli, A., Peyre, H., Speranza, M., Hassler, C., Falissard, B., Touchette, E., Cohen, D., Moro, M.-R., & Révah-Lévy, A. (2013) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-7-8 · Cited by 149
“Indeed, the family factors, and especially the perceived quality of family relationships, have been pinpointed as an important risk or protective factor in clinical and community samples of adolescents [1,2,6,21-26].”
BackgroundMundt, J. C., Greist, J. H., Jefferson, J. W., Federico, M., Mann, J. J., & Posner, K. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08398 · Cited by 152
Kennard, B. D., Goldstein, T., Foxwell, A. A., McMakin, D. L., Wolfe, K., Biernesser, C., Moorehead, A., Douaihy, A., Zullo, L., Wentroble, E., et al. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.17101151 · Cited by 154
“, increase in suicidal ideation or suicide attempt) occur within the first 3 weeks of outpatient treatment following discharge (16,17), meaning that even rapid referral to outpatient care may only partially obviate the high rate of suicidal behavior post-discharge.”
BackgroundSelf-citationBlunted HPA Axis Activity in Suicide Attempters Compared to those at High Risk for Suicidal Behavior
Melhem, N. M., Keilp, J. G., Porta, G., Oquendo, M. A., Burke, A., Stanley, B., Cooper, T. B., Mann, J. J., & Brent, D. A. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.309 · Cited by 143
“We also include suicidal ideation that prompted emergency referral during the study because the referral may have prevented suicidal behavior, which we have previously included with SRBs and is commonly included with suicidal events in treatment studies (Brent et al, 2009, Melhem et al, 2007).”
MethodSelf-citationHopelessness as a Predictor of Suicide Ideation in Depressed Male and Female Adolescent Youth
Wolfe, K. L., Nakonezny, P. A., Owen, V. J., Rial, K. V., Moorehead, A., Kennard, B. D., & Emslie, G. J. (2017) · Suicide and Life-Threatening Behavior · doi:10.1111/sltb.12428 · Cited by 154
Self-citationBrent, D., Melhem, N., Ferrell, R., Emslie, G., Wagner, K. D., Ryan, N., Vitiello, B., Birmaher, B., Mayes, T., Zelazny, J., et al. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09040576 · Cited by 138
Self-citationVitiello, B., Emslie, G., Clarke, G., Wagner, K. D., Asarnow, J. R., Keller, M. B., Birmaher, B., Ryan, N. D., Kennard, B., Mayes, T. L., et al. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05885blu · Cited by 128
Self-citationWilkinson, P. O. (2012) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-012-0365-7 · Cited by 146
“In contrast neither led to a significant additional reduction in self-injury, whether suicidal and non-suicidal self-injury were classified together [22] or separately [23].”
BackgroundMeyer, R. E., Salzman, C., Youngstrom, E. A., Clayton, P. J., Goodwin, F. K., Mann, J. J., Alphs, L. D., Broich, K., Goodman, W. K., Greden, J. F., et al. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10cs06070blu · Cited by 129
Self-citationArbuthnott, A. E., & Lewis, S. P. (2015) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-015-0066-3 · Cited by 137
Psychotherapeutic approaches to non-suicidal self-injury in adolescents
Washburn, J. J., Richardt, S. L., Styer, D. M., Gebhardt, M., Juzwin, K. R., Yourek, A., & Aldridge, D. (2012) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-6-14 · Cited by 98
Antidepressants and Suicidality
Brent, D. A. (2016) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2016.04.002 · Cited by 119
Self-citationCombined treatment with cognitive–behavioural therapy in adolescent depression: meta-analysis
Dubicka, B., Elvins, R., Roberts, C., Chick, G., Wilkinson, P., & Goodyer, I. M. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.075853 · Cited by 116
Murphy, S. E., Capitão, L. P., Giles, S. L. C., Cowen, P. J., Stringaris, A., & Harmer, C. J. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00154-1 · Cited by 112
The Next Generation of Psychological Autopsy Studies: Part I. Interview Content
Conner, K. R., Beautrais, A. L., Brent, D. A., Conwell, Y., Phillips, M. R., & Schneider, B. (2011) · Suicide and Life-Threatening Behavior · doi:10.1111/j.1943-278x.2011.00057.x · Cited by 110
Self-citationNonsuicidal Self‐Injury Is Predictive of Suicide Attempts Among Individuals with Mood Disorders
Chesin, M. S., Galfavy, H., Sonmez, C. C., Wong, A., Oquendo, M. A., Mann, J. J., & Stanley, B. (2017) · Suicide and Life-Threatening Behavior · doi:10.1111/sltb.12331 · Cited by 105
“Brent et al. (2009) have found that consistent, systematic monitoring, as compared to reliance on a single, retrospective report, increases the accuracy of NSSI assessment.”
BackgroundResultTreatment-resistant depression in adolescents: review and updates on clinical management
Maalouf, F. T., Atwi, M., & Brent, D. A. (2011) · Depression and Anxiety · doi:10.1002/da.20884 · Cited by 99
“[22] In the TORDIA study, better outcome was associated with higher blood concentration of drug, at least for fluoxetine and citalopram, and higher adherence was also associated with a better outcome.”
BackgroundMethodResultInfluentialSelf-citationStrawn, J. R., Mills, J. A., Sauley, B. A., & Welge, J. A. (2018) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2018.01.015 · Cited by 98
Depressive disorders in childhood and adolescence
Brent, D., & Maalouf, F. (2015) · Rutter's Child and Adolescent Psychiatry · doi:10.1002/9781118381953.ch63 · Cited by 94
Self-citationThe Columbia-Suicide Severity Rating Scale (C-SSRS): Has the "Gold Standard" Become a Liability?
Giddens, J. M., Sheehan, K. H., & Sheehan, D. V. (2014) · Europe PMC (PubMed Central) · Cited by 130
Genome-Wide Association Study of Antidepressant Treatment-Emergent Suicidal Ideation
Menke, A., Domschke, K., Czamara, D., Klengel, T., Hennings, J. M., Lucae, S., Baune, B. T., Arolt, V., Müller‐Myhsok, B., Holsboer, F., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.257 · Cited by 97
“Although efforts are made to find predictors for young patients at risk (Brent et al, 2009; Posner et al, 2007), reliable predictorsFincluding genetic markersFfor adult patients are still missing.”
BackgroundReports of suicidality in clinical trials of montelukast
Philip, G., Hustad, C. M., Noonan, G. P., Malice, M., Ezekowitz, A. B., Reiss, T. F., & Knorr, B. A. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.08.010 · Cited by 92
Kang, C., Zheng, Y., Yang, L., Wang, X., Zhao, N., Guan, T. F., Qiu, S., Shi, J., & Hu, J. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.04.073 · Cited by 85
Dardas, L. A., van de Water, B. J., & Simmons, L. A. (2017) · International Journal of Mental Health Nursing · doi:10.1111/inm.12429 · Cited by 85
Treating nonsuicidal self-injury (NSSI) in adolescents: consensus based German guidelines
Plener, P. L., Brunner, R., Fegert, J. M., Groschwitz, R. C., In-Albon, T., Kaess, M., Kapusta, N. D., Resch, F., & Becker, K. (2016) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-016-0134-3 · Cited by 63
“As higher rates of NSSI in those receiving benzodiazepines have been reported from the TORDIA study [47] and another study reported a lack of efficacy in treating NSSI with these compounds [48], the use of benzodiazepines should be restricted to clearly defined cases and weighing the risk–benefit ratio on an individua…”
BackgroundCox, G. R., Callahan, P., Churchill, R., Hunot, V., Merry, S. N., Parker, A. G., & Hetrick, S. E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008324.pub2 · Cited by 70
Family processes: risk, protective and treatment factors for youth at risk for suicide.
Diamond, G., Kodish, T., Ewing, E. S. K., Hunt, Q. A., & Russon, J. M. (2022) · Aggression and Violent Behavior · doi:10.1016/j.avb.2021.101586 · Cited by 70
Challenges of Managing Pediatric Mental Health Crises in the Emergency Department
Chun, T. H., Katz, E. R., Duffy, S. J., & Gerson, R. S. (2014) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2014.09.003 · Cited by 69
Feasibility of attachment based family therapy for depressed clinic-referred Norwegian adolescents
Israel, P., & Diamond, G. S. (2013) · Clinical Child Psychology and Psychiatry · doi:10.1177/1359104512455811 · Cited by 61
“To date, anti-depressant medication and Cognitive Behavioural Therapy (CBT), alone and in combination, have received the most research attention for treatment of this population (Brent et al., 2009; Goodyer et al., 2007; March et al., 2004).”
BackgroundMills, J. A., & Strawn, J. R. (2020) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2019.10.013 · Cited by 56
The prevalence of depressive symptoms among Arab adolescents: Findings from Jordan
Dardas, L. A., Silva, S. G., Smoski, M. J., Noonan, D., & Simmons, L. A. (2018) · Public Health Nursing · doi:10.1111/phn.12363 · Cited by 62
“Positive parenting and a supportive cohesive family environment are considered protective factors in preventing depression and suicide (Brent et al., 2009; Sheeber, Davis, Leve, Hops, & Tildesley, 2007).”
BackgroundChild and Adolescent Depression Intervention Overview: What Works, for Whom and How Well?
Maalouf, F. T., & Brent, D. A. (2012) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2012.01.001 · Cited by 72
Self-citationRengasamy, M., Mansoor, B. M., Hilton, R., Porta, G., He, J., Emslie, G. J., Mayes, T., Clarke, G. N., Wagner, K. D., Keller, M. B., et al. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.01.012 · Cited by 57
Self-citationEliciting adverse effects data from participants in clinical trials
Allen, E. N., Chandler, C. I., Mandimika, N., Leisegang, C., & Barnes, K. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000039.pub2 · Cited by 52
Suicide in the pediatric population: screening, risk assessment and treatment
Cwik, M. F., O’Keefe, V. M., & Haroz, E. E. (2020) · International Review of Psychiatry · doi:10.1080/09540261.2019.1693351 · Cited by 58
Predictors of serious suicidal behavior in late-life depression
Szántó, K., Galfalvy, H., Kenneally, L. B., Almasi, R. C., & Dombrovski, A. Y. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.06.005 · Cited by 59
“In contrast, interpersonal difficulties and impulsivity will predict lower-lethality suicide-related behavior (referred to as less lethal suicide events), including attempts that were low-medical lethality or aborted, as well as emergency referrals to psychiatric hospitals to prevent suicide, which are commonly includ…”
BackgroundWoldu, H., Porta, G., Goldstein, T., Sakolsky, D., Perel, J., Emslie, G., Mayes, T., Clarke, G., Ryan, N. D., Birmaher, B., et al. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2011.01.018 · Cited by 51
Self-citationSelbstverletzendes Verhalten im Jugendalter
Plener, P. L., Brunner, R. M., Resch, F., Fegert, J. M., & Libal, G. (2010) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917.a000015 · Cited by 61
Maalouf, F. T., Porta, G., Vitiello, B., Emslie, G. J., Mayes, T. L., Clarke, G., Wagner, K. D., Asarnow, J. R., Spirito, A., Keller, M. B., et al. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.12.021 · Cited by 58
“The design, methods, and results of TORDIA have been reported in detail elsewhere (Asarnow et al., 2009; Brent et al., 2008, 2009; Emslie et al., 2010; Vitiello et al., 2010).”
Self-citationAsarnow, J. R., Porta, G., Spirito, A., Emslie, G. J., Clarke, G. N., Wagner, K. D., Vitiello, B., Keller, M. B., Birmaher, B. B., McCracken, J., et al. (2012) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.10.3.380 · Cited by 53
Self-citationFontanella, C. A., Campo, J. V., Phillips, G. S., Steelesmith, D. L., Sweeney, H. A., Tam, K. K., Lehrer, D. S., Klein, R. W., & Hurst, M. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15m10271 · Cited by 56
Youth suicide prevention: does access to care matter?
Campo, J. V. (2009) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32833069bd · Cited by 52
Gormley, B., & McNiel, D. E. (2009) · Cognitive Therapy and Research · doi:10.1007/s10608-009-9267-5 · Cited by 59
“Assessing history of suicide attempts and self-injury through questions such as these is widespread in the literature (e.g., Brent et al. 2009; Kessler et al. 1999; Klonsky et al. 2003; Nixon et al. 2008; Welch 2001; Weissman et al. 1999).”
BackgroundUnderstanding the effects of chronic benzodiazepine use in depression: a focus on neuropharmacology
Lim, B., Sproule, B. A., Zahra, Z., Sunderji, N., Kennedy, S. H., & Rizvi, S. J. (2020) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000316 · Cited by 50
Strawn, J. R., Mills, J. A., Suresh, V., Peris, T. S., Walkup, J. T., & Croarkin, P. E. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.10.047 · Cited by 49
Strawn, J. R., Mills, J. A., Suresh, V., Mayes, T. L., Gentry, M. T., Trivedi, M. H., & Croarkin, P. E. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.01.043 · Cited by 50
Self-citationPharmacogenomics of Suicidal Events
Brent, D., Melhem, N., & Turecki, G. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.64 · Cited by 46
Self-citationMeister, R., von Wolff, A., Mohr, H., Nestoriuc, Y., Härter, M. C., Hölzel, L. P., & Kriston, L. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.10.007 · Cited by 48
Tomas-Aragones, L., Consoli, S., Consoli, S. G., Poot, F., Taube, K., Linder, M. D., Jemec, G. B. E., Szepietowski, J. C., de Korte, J., Lvov, A. N., et al. (2016) · Acta Dermato Venereologica · doi:10.2340/00015555-2522 · Cited by 50
Pharmacotherapy of major depressive disorder in adolescents
Masi, G., Liboni, F., & Brovedani, P. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903527226 · Cited by 42
“In the TORDIA study [29], which included 334 adolescents withMDD,predictorsof self-harmadverseeventswereexplored with spontaneous reports for the first 181 patients and by systematicweekly assessment for the remaining153patients [56].”
MethodAn update on antidepressant use and suicidality in pediatric depression
Adeniyi, C., Gron, B. A., Rowles, B. M., Demeter, C., & Findling, R. L. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.726613 · Cited by 48
“Useful prospectively collected data regarding suicidal behavior in children and adolescents with depression have been provided from a multisite, double-blind, randomized, placebo-controlled trials of escitalopram [55], the Treatment for Adolescents with Depression Study (TADS) [63,64], TORDIA [56,57], Adolescent Depre…”
BackgroundMethodResultInfluentialParent–teen communication predicts treatment benefit for depressed and suicidal adolescents.
Zisk, A., Abbott, C. H., Bounoua, N., Diamond, G. S., & Kobak, R. (2019) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000457 · Cited by 36
“These perceived measures of family conflict and lack of family cohesion predicted poorer treatment response among depressed adolescents receiving cognitive-behavioral therapy (CBT) and/or pharmacological intervention (Asarnow et al., 2009; Feeny et al., 2009; Rengasamy et al., 2013) as well as among depressed adolesce…”
BackgroundInfluentialShamseddeen, W. A., Clarke, G. N., Keller, M. B., Wagner, K. D., Birmaher, B. B., Emslie, G. J., Ryan, N. D., Asarnow, J. R., Porta, G., & Brent, D. A. (2012) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0027 · Cited by 44
“Self-harm events were highly associated with nonresponse, as has been previously demonstrated in this and other samples (Asarnow et al. 2009; Brent et al. 2009; Vitiello et al. 2009).”
Self-citationEarly changes of serum BDNF and SSRI response in adolescents with major depressive disorder
Lee, J., Lee, K. H., Kim, S. H., Han, J. Y., Hong, S.-B., Cho, S.-C., Kim, J.-W., & Brent, D. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.045 · Cited by 37
Self-citationDevenish, B., Berk, L., & Lewis, A. J. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415627374 · Cited by 33
“The TASA study was aimed at treating depression in adolescents who had recently attempted suicide and treatment involved CBT therapy for adult suicide attempters modified extensively to better meet the needs of depressed and suicidal adolescents (Brent et al., 2009b).”
InfluentialSocial Functioning and Suicide Risk in a Community Sample of Adolescents
Meter, A. V., Paksarian, D., & Merikangas, K. R. (2019) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2018.1528549 · Cited by 41
“In addition, because mood disorders are associated with high rates of suicide (Brent et al., 2009; Garlow et al., 2008; Goldstein et al., 2005), and the disorder itself may account for much of the variance in risk, it is possible that friend and family relationships would have a smaller association…”
BackgroundFamily functioning moderates the impact of depression treatment on adolescents’ suicidal ideations
Dardas, L. A. (2019) · Child and Adolescent Mental Health · doi:10.1111/camh.12323 · Cited by 37
Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review
Mann, J. J., Michel, C. A., & Auerbach, R. P. (2023) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.23021004 · Cited by 38
“Three randomized controlled trials in adolescents and young adults found that antidepressants reduced suicidal ideation (62, 64, 65), one study did not (85), and none found a reduction in suicidal behavior.”
A Bibliography of Randomized Controlled Experiments in Social Work (1949–2013): Solvitur Ambulando
Thyer, B. A. (2015) · Research on Social Work Practice · doi:10.1177/1049731515599174 · Cited by 36
Initial Validity and Reliability Data on the Columbia–Suicide Severity Rating Scale
Chappell, P. B., Feltner, D. E., Makumi, C. W., & Stewart, M. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12010123 · Cited by 34
Mufson, L. H. (2010) · Child and Adolescent Mental Health · doi:10.1111/j.1475-3588.2009.00556.x · Cited by 33
Hetrick, S. E., Simmons, M., Thompson, A., & Parker, A. G. (2011) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2011.619161 · Cited by 29
Aouidad, A., Cohen, D., Mirkovic, B., Pellerin, H., Garny de La Rivière, S., Consoli, A., Gérardin, P., & Guilé, J.-M. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02930-4 · Cited by 32
Safeguarding Childrens Rights in Psychopharmacological Research: Ethical and Legal Issues
Kölch, M. G., Ludolph, A. G., Plener, P. L., Fangerau, H., Vitiello, B., & Fegert, J. M. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791959881 · Cited by 36
“The most compelling issue that emerged from the SSRI debate is that safety needs to be assessed in an appropriate manner [73].”
BackgroundSelf-citationKorczak, D. J., Finkelstein, Y., Barwick, M. A., Chaim, G., Cleverley, K., Henderson, J. L., Monga, S., Moretti, M. E., Willan, A. R., & Szatmári, P. (2020) · BMC Psychiatry · doi:10.1186/s12888-019-2422-y · Cited by 36
Plener, P. L., Fegert, J. M., Kaess, M., Kapusta, N. D., Brunner, R. M., Groschwitz, R. C., In‐Albon, T., Resch, F., & Becker, K. (2016) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917/a000463 · Cited by 35
Hetrick, S. E., Goodall, J., Yuen, H. P., Davey, C. G., Parker, A. G., Robinson, J., Rickwood, D. J., McRoberts, A., Sanci, L., Gunn, J., et al. (2017) · Crisis · doi:10.1027/0227-5910/a000422 · Cited by 31
“This potentially compromises appropriate treatment planning and risk management because previous research has highlighted that a reliance on spontaneous report does not sufficiently identify all those at risk of suicide (Brent et al., 2009).”
BackgroundJeong, Y. W., Chang, H. J., & Kim, J. A. (2020) · CIN Computers Informatics Nursing · doi:10.1097/cin.0000000000000592 · Cited by 36
“Safety plans are a useful intervention for managing suicide crises.(2,11) Safety plans are brief (20–40 minutes), highly structured interventions wherein patients develop a written, personalized list of coping strategies and individuals they can contact for support in a suicidal crisis.”
BackgroundSuresh, V., Mills, J. A., Croarkin, P. E., & Strawn, J. R. (2020) · Depression and Anxiety · doi:10.1002/da.23064 · Cited by 30
“Additional details about the trial (Emslie, 2008) and its results have been described elsewhere (Brent et al., 2009; Emslie, 2008; Emslie et al., 2010; Kennard et al., 2009; Mansoor et al., 2013; Sakolsky et al., 2011; Strawn et al., 2019).”
BackgroundResultNeurological entanglements: The case of paediatric depressions, SSRIs and suicidal ideation
Wilson, E. (2011) · Subjectivity · doi:10.1057/sub.2011.12 · Cited by 31
Slesnick, N., Zhang, J., Feng, X., Wu, Q., Walsh, L., & Granello, D. H. (2019) · Cognitive Therapy and Research · doi:10.1007/s10608-019-10068-1 · Cited by 31
Pediatric Mental Health Emergencies and Special Health Care Needs
Chun, T. H., Katz, E. R., & Duffy, S. J. (2013) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2013.06.006 · Cited by 32
“However, many may not proactively report their suicidality to providers.(22) Given the prevalence of suicidal ideation and attempts as well as the morbidity and mortality associated with attempts, pediatric providers are encouraged to screen all of their teen patients for suicidality.”
BackgroundAlphs, L. D., Fu, D., Williamson, D., Turkoz, I., Jamieson, C., Revicki, D. A., & Canuso, C. M. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113495 · Cited by 28
“Data regarding inter-rater reliability of the C-SSRS are limited (Brent et al., 2009; Giddens et al., 2014; Mundt et al., 2010).”
BackgroundEggart, V., Cordier, S., Hasan, A., & Wagner, E. M. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01385-w · Cited by 27
“[31, 36], a non-randomized, open-label “add-on treatment” with trazodone (N = 33) was compared vs.”
BackgroundMethodResultInfluential
Metadata
- Authors
- Brent, D. A., Emslie, G. J., Clarke, G. N., Asarnow, J., Spirito, A., Ritz, L., Vitiello, B., Iyengar, S., Birmaher, B., Ryan, N. D., Zelazny, J., Onorato, M., Kennard, B., Mayes, T. L., DeBar, L. L., McCracken, J. T., Strober, M., Suddath, R., Leonard, H., Porta, G., & Keller, M. B.
- Affiliations
- University of Pittsburgh (US)
- ORCID
- Venue
- American Journal of Psychiatry
- Published
- 2009-04
- Volume
- 166
- Issue
- 4
- Pages
- 418-426
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- PMC
- PMC3593721
- OpenAlex
- W2124714257
- Cited by
- 235
- References
- 34
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 4 · 2023: 17 · 2022: 7 · 2021: 14 · 2020: 19 · 2019: 12 · 2018: 10 · 2017: 10 · 2016: 13 · 2015: 10 · 2014: 14 · 2013: 17 · 2012: 25
- FWCI
- 27.29
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Pfizer
- National Institute of Mental Health (U01MH061835, U01MH062014)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- non-suicidal self-injury, treatment-resistant depression, adolescent depression, SSRI antidepressants, venlafaxine, cognitive behavioral therapy, suicidal ideation, family conflict, benzodiazepines, adverse event monitoring
- MeSH terms
- Venlafaxine Hydrochloride, Adolescent, Antidepressive Agents, Benzodiazepines, Cross-Sectional Studies, Cyclohexanols, Major Depressive Disorder, Depressive Disorder, Major, Drug Interactions, Drug Resistance, Drug Therapy, Combination, Female, Fluoxetine, Humans, Male, Suicide, Suicide, Attempted, Citalopram, Cognitive Behavioral Therapy, Self-Injurious Behavior, Selective Serotonin Reuptake Inhibitors, Paroxetine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.